China sets new ethics rules for human studies

Dennis Normile

DOI: https://doi.org/10.1126/science.adh4963

IF: 56.9

2023-03-10

Science

Abstract:Revised regulations follow controversy over work that created genetically edited babies.

What problem does this paper attempt to address?

Ethics: China already has clear stem-cell guidelines

Linzhao Cheng,Ren-Zong Qiu,Hongkui Deng,Yu Alex Zhang,Ying Jin,Lingsong Li

DOI: https://doi.org/10.1038/440992b

IF: 64.8

2006-01-01

Nature

Abstract:As scientists and ethicists who care about stem-cell research in China, we disagree with the statement in your News story “Panel clarifies stem-cell rules” (Nature 440, 9; 2006) that “China lacks clear national policies, with different institutes following different rules”.In fact, China's government has issued several guidelines to regulate human stem-cell research.
How should China set ethical guardrails for medical research?

Jingyi Xu,Zhongxuan Liu,Jiayou Shi,Yue Wang

DOI: https://doi.org/10.1136/jme-2023-109621

2023-12-19

Journal of Medical Ethics

Abstract:‘Ethics first’ reform in China significantly changes the governance framework for the research of emerging technologies. The misapplication of human genome editing technology reflects the urgent need to reform the governance framework. Strengthening ethics governance in medical research has become a consensus in China, where legal and ethical reforms are proceeding in parallel. The protection of human dignity, the prevention of biosafety risks, as well as the regulation of technological crimes are at the core of the legal system, which has been embodied in numerous fundamental legislations following the CRISPR-babies incident. Establishing a national ethics committee to coordinate ethics governance, and reinforcing ethics review and external oversight are significant steps in ethical reform. Essentially, ethics governance requires implementing the basic concept of ‘ethics first’, focusing on forward-looking and preventive governance rather than delayed intervention, while maintaining openness and collaboration.

ethics,medical ethics,social issues,social sciences, biomedical
Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

X Mao

DOI: https://doi.org/10.1086/302020

Abstract:To identify Chinese geneticists' views of ethical issues in genetic testing and screening, a national survey was conducted. Of 402 Chinese geneticists asked to participate, 255 (63%) returned by mail anonymous questionnaires. The majority of respondents thought that genetic testing should be offered in the workplace for alpha-antitrypsin deficiency (95%) and the predisposition of executives to heart disease, cancer, and diabetes (94%); that genetic testing should be included in preemployment physical examinations (86%); that governments should require premarital carrier tests (86%), newborn screening for sickle cell (77%), and Duchenne muscular dystrophy (71%); and that children should be tested for genes for late-onset disorders such as Huntington disease (85%), susceptibility to cancers (85%), familial hypercholesterolemia (84%), alcoholism (69%), and Alzheimer disease (61%). Most believed that partners should know each other's genetic status before marriage (92%), that carriers of the same defective gene should not mate with each other (91%), and that women should have a prenatal diagnosis if medically indicated (91%). The majority said that in China decisions about family planning were shared by the couple (82%). More than half had views that, in China, there were no laws to prohibit disability discrimination (64%), particularly to protect people with adult polycystic kidney disease (57%), cystic fibrosis (56%), or genetic predisposition to other diseases (50%). To some extent, these results might provide a basis for a discussion of eugenics in China, particularly about China's Maternal and Infant Health Care Law (1994).
Experiments that led to the first gene-edited babies: the ethical failings and the urgent need for better governance

Jing-Ru Li,Simon Walker,Jing-Bao Nie,Xin-Qing Zhang

DOI: https://doi.org/10.1631/jzus.B1800624

Abstract:The rapid developments of science and technology in China over recent decades, particularly in biomedical research, have brought forward serious challenges regarding ethical governance. Recently, Jian-kui HE, a Chinese scientist, claimed to have "created" the first gene-edited babies, designed to be naturally immune to the human immunodeficiency virus (HIV). The news immediately triggered widespread criticism, denouncement, and debate over the scientific and ethical legitimacy of HE's genetic experiments. China's guidelines and regulations have banned germline genome editing on human embryos for clinical use because of scientific and ethical concerns, in accordance with the international consensus. HE's human experimentation has not only violated these Chinese regulations, but also breached other ethical and regulatory norms. These include questionable scientific value, unreasonable risk-benefit ratio, illegitimate ethics review, invalid informed consent, and regulatory misconduct. This series of ethical failings of HE and his team reveal the institutional failure of the current ethics governance system which largely depends on scientist's self-regulation. The incident highlights the need for urgent improvement of ethics governance at all levels, the enforcement of technical and ethical guidelines, and the establishment of laws relating to such bioethical issues.
Conflict of Interest in Scientific Research in China: A Socio-ethical Analysis of He Jiankui’s Human Genome-editing Experiment

Nie Jing-Bao,Xie Guangkuan,Chen Hua,Cong Yali

DOI: https://doi.org/10.1007/s11673-020-09978-7

2020-01-01

Journal of Bioethical Inquiry

Abstract:Extensive conflicts of interest (COI) at both individual and institutional levels are identifiable in scientific research and healthcare in China, as in many other parts of the world. A prominent new case from China is He Jiankui’s experiment that produced the world’s first gene-edited babies and that raises numerous ethical, political, socio-cultural, and transnational questions. Serious financial and other COI were involved in He’s genetic adventure. Using He’s infamous experiment as a case study, this paper explores the wider issue of financial and other COI in scientific research and healthcare in China, especially institutional conflict of interest (ICOI) and policy-related COI. Taking a socio-ethical perspective, it examines China’s state policies and its massive efforts to transform and commercialize scientific research, the lack of policies and oversight mechanisms for regulating COI, as well as major ethical issues arising from COI including the undermining of public trust. Some practical suggestions are offered for institutional reform and institutional development so that COI, particularly ICOI, can be avoided or more effectively managed in scientific research in China.
Debating Ethical Issues in Genome Editing Technology

R. Qiu

DOI: https://doi.org/10.1353/ASB.2016.0026

2016-12-29

Abstract:This paper provides an ethical analysis of the controversy that arose from the CRISPR/Cas9 gene editing research involving human embryos that was conducted by a research team in Guangzhou, China, in 2015. It is argued that the researchers involved did not overstep ethical boundaries. This was confirmed to be the case in an international meeting of experts that was convened following the controversy. It is further argued that the controversy highlights the tension between two fundamentally different policies on developing genome editing technology – one proactionary and the other precautionary. This paper argues for a third approach, based on the policy of “crossing the river by probing stones”. Such an approach is consistent with current international recommendations to prioritise basic and pre-clinical research, and to allow the application of genome editing technology to somatic human cells. However, the application of the technology in germline genetic modification for human reproduction or enhancement for medical purposes should not be allowed at present. This is because the attending risks are not well understood and could be excessive or extraordinary, with little or no prospect of benefit. In addition, this paper calls for norms and regulations to be developed for genetically modifying non-human living things. Finally, the paper concludes with a letter that was sent by the author (and another) to the New York Times, setting out China’s fundamental stance on genetic modification involving humans and human derivatives.

Biology,Sociology,Philosophy,Medicine
Patient privacy and autonomy: a comparative analysis of cases of ethical dilemmas in China and the United States

Hui Zhang,Hongmei Zhang,Zhenxiang Zhang,Yuming Wang

DOI: https://doi.org/10.1186/s12910-021-00579-6

2021-02-02

BMC Medical Ethics

Abstract:Abstract Background Respect for patients’ autonomy is usually considered to be an important ethical principle in Western countries; privacy is one of the implications of such respect. Healthcare professionals frequently encounter ethical dilemmas during their practice. The past few decades have seen an increased use of courts to resolve intractable ethical dilemmas across both the developed and the developing world. However, Chinese and American bioethics differ largely due to the influence of Chinese Confucianism and Western religions, respectively, and there is a dearth of comparative studies that explore cases of ethical dilemmas between China and the United States. Methods This paper discusses four typical cases with significant social impact. First, it compares two cases concerning patient privacy: the “Shihezi University Hospital Case”, in which a patient was used as a clinical teaching object without her permission, and the “New York-Presbyterian Hospital Case”, in which the hospital allowed the filming of a patient’s treatment without his consent. Second, it compares two cases regarding patient autonomy and potentially life-saving medical procedures: the “Case of Ms. L”, concerning a cohabitant’s refusal to sign a consent form for a pregnant woman’s caesarean, and the “Case of Mrs. V”, concerning a hospital’s insistence upon a blood transfusion for a dissenting patient. This paper introduces the supporting and opposing views for each case and discusses their social impact. It then compares and analyses the differences between China and the United States from cultural and legislative perspectives. Conclusions Ethical dilemmas have often occurred in China due to the late development of bioethics. However, the presence of bioethics earlier in the US than in China has not spared the US of ethical dilemmas. This paper highlights lessons and inspiration from the cases for healthcare professionals and introduces readers to the role and weight of privacy and autonomy in China and in the US from the perspectives of different cultures, religions and laws.

ethics,medical ethics,social sciences, biomedical
Breaking the germline barrier in a moral vacuum

Sheldon Krimsky

DOI: https://doi.org/10.1080/08989621.2019.1644171

Abstract:In November 2018 a Chinese scientist claimed to have used CRISPR/Cas 9 technology to genetically modify two human embryos that were then gestated in one adult woman through an IVF pregnancy and brought to term. The twin girls are allegedly the first babies born with their prenatal genomes edited. Using both English language and Chinese supporting documents, this paper discusses the background of this human experiment, the social context of Chinese science, and the alleged ethical transgressions of its principal scientist.
Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China

Yao-Jin Peng,Xiaoru Huang,Qi Zhou

DOI: https://doi.org/10.1016/j.stem.2020.09.010

IF: 23.9

2020-10-01

Cell Stem Cell

Abstract:China's stem cell research policies are based on a cultural understanding that grants special protection to human embryos but does not assign them equivalent moral or legal status as fully developed humans. We discuss ethical considerations for embryo research and policy changes as China moves toward adopting internationally recognized rules.

cell biology,cell & tissue engineering
China's New Regulations on Generative AI: Implications for Bioethics.

Li Du,Kalina Kamenova

DOI: https://doi.org/10.1080/15265161.2023.2249854

2023-01-01

Abstract:Click to increase image sizeClick to decrease image sizeThis article refers to:What Should ChatGPT Mean for Bioethics? DISCLOSURE STATEMENTNo potential conflict of interest was reported by the author(s).Additional informationFundingThis work was supported by the University of Macau Li Du – Multi-Year Research Grant (No. 2020-00096).
Translational Bioethics in China: Brain-Computer Interface Research as a Case Study

Haidan Chen

DOI: https://doi.org/10.1002/eahr.500224

Abstract:The research and development of emerging technologies has potential long-term and societal impacts that pose governance challenges. This essay summarizes the development of research ethics in China over the past few decades, as well as the measures taken by the Chinese government to build its ethical governance system of science and technology after the occurrence of the CRISPR-babies incident. The essay then elaborates on the current problems of this system through the case study of ethical governance of brain-computer interface research, and explores how the transition from research ethics to translational bioethics, which encourages interdisciplinary collaboration and focuses on societal implications, may respond to the challenges of ethical governance of science and technology.
UK Scientists Reject Call for Moratorium on Gene Editing

Nigel Hawkes

DOI: https://doi.org/10.1136/bmj.h2601

2015-01-01

BMJ

Abstract:New techniques for editing genes, used for the first time in human embryos by researchers in China, have considerable potential as a research tool and are already being used in animals, UK experts told a briefing at the Science Media Centre in London on 12 May. Clinical applications in humans are far more problematical and much further off, and the use of the technique has raised ethical concerns, because such changes are heritable and could have unpredictable effects on future generations. The UK scientists, however, rejected calls for a moratorium. Tony Perry of the University of Bath said it would be unenforceable and would risk driving research underground, and Robin Lovell-Badge of the Francis Crick Institute called a moratorium “pointless.” The disclosure that a group led by Junjiu Huang at Sun Yat-sen University in Guangzhou had edited human embryonic genes caused a …
Recent Developments in the Regulation of Heritable Human Genome Editing

S Soni

DOI: https://doi.org/10.1007/s11673-023-10332-w

Abstract:In 2018, the Chinese scientist He Jiankui presented his research at the Second International Summit on Human Genome Editing in Hong Kong. While it was intended that he facilitate a workshop, he was instead called on to present his research in heritable human genome editing, where he made the announcement that he had taken great strides in advancement of his research, to the extent that he had gene-edited human embryos and that this had resulted in the live births of two children. While his research ethic and methodology was interrogated, he insisted that two children, twin girls, had been born healthy and that there was another pregnancy (at the time) where birth of a third gene edited child would be imminent. This announcement generated a ripple effect in the scientific community and exposed the gaps in regulation and absence of law relating to the technology. This resulted in a flurry of activity and conversation around regulation of the technology, which scientists stated was not ready for human trials. This article reviews the Third Summit which was held in London in March 2023 and comments on the latest developments in the regulation of heritable human genome editing.
Ethics Committees Promote Responsible Research in China

Guoyu Wang

DOI: https://doi.org/10.1038/s41562-024-01917-5

IF: 24.252

2024-01-01

Nature Human Behaviour

Abstract:Guoyu Wang leads and serves on Chinese ethics committees. She explains how research ethics have developed in China, and why ethics review promotes responsible innovation.
Before and after the Chinese gene-edited human babies: Multiple discourses of gene editing on social media

Xing Zhang,Anfan Chen,Weiyu Zhang

DOI: https://doi.org/10.1177/0963662520987754

2021-01-19

Public Understanding of Science

Abstract:This study examines discourses in Chinese online discussions of gene editing by multiple social actors on Weibo before and after a significant scientific crisis, the 2018 scandal of Chinese gene-edited human babies. A content analysis of 2074 posts was done to identify frames, emotions, and metaphors. Findings reveal that Chinese social media have opened up new spaces for multiple social actors to generate multiple discourses. This has resulted in a more participatory public engagement with science and technology on Chinese social media, potentially influencing the online agenda and policy decisions on science and technology. Finally, findings indicate that a scientific crisis can serve as a trigger for significant changes in public attitudes and opinions regarding gene editing.

communication,history & philosophy of science
Comments on the CRISPR Gene-edited Babies’ Case

Yali Cong

DOI: https://doi.org/10.20529/ijme.2019.039

2019-01-01

Abstract:Twin girls were born in China in November 2018 to an HIV-positive father and an HIV-negative mother, through in vitro fertilisation in combination with CRISPR-Cas9 genome editing which altered their CCR5 genes. An investigation found that regulations were broken, and documents were forged. The government needs to address various regulatory defects, improve oversight of research, and implement institutional policies on conflict of interest.
An ethical pathway for gene editing.

P. Singer,J. Savulescu

DOI: https://doi.org/10.1111/bioe.12570

2019-01-29

Bioethics

Abstract:The central importance of ethics to science is exquisitely illustrated by the recent gene editing of two healthy embryos by the Chinese biophysicist He Jiankui, resulting in the birth of baby girls born this month, Lulu and Nana. A second pregnancy is underway with a different couple. To make the babies resistant to HIV, He edited out a gene (CCR5) that produces a protein which allows HIV to enter cells. One girl has both copies of the gene modified (and may be resistant to HIV), while the other has only one (making her still susceptible to HIV).1

Medicine,Psychology,Philosophy,Biology
China's regulatory change toward genome-edited crops

Fei Yang,Kaili Zheng,Yu Yao

DOI: https://doi.org/10.1016/j.tibtech.2023.12.008

Abstract:China's newly issued genome-edited crop safety assessment guidelines do not entirely deviate from the existing genetically modified regulatory regimes. However, there is an urgent need to reform the genome-edited regulatory framework based on scientific values and a novel regulatory philosophy that balances diverse values to enhance public trust.
Germline genome editing of human IVF embryos should not be subject to overly stringent restrictions

Kevin Richard Smith

DOI: https://doi.org/10.1007/s10815-024-03174-x

Abstract:This paper critiques the restrictive criteria for germline genome editing recently proposed by Chin, Nguma, and Ahmad in this journal. While praising the authors for resisting fervent calls for an outright ban on clinical applications of the technology, this paper argues that their approach is nevertheless unduly restrictive, and may thus hinder technological progress. This response advocates for weighing potential benefits against risks without succumbing to excessive caution, proposing that ethical oversight combined with genetic scrutiny at the embryo stage post-editing can enable responsible use of the technology, ultimately reducing the burden of genetic diseases and enhancing human health, akin to how IVF transformed reproductive medicine despite strong initial opposition.
The CRISPR-baby scandal: what’s next for human gene-editing

David Cyranoski

DOI: https://doi.org/10.1038/d41586-019-00673-1

IF: 64.8

2019-02-01

Nature

Abstract:As concerns surge after a bombshell revelation, here are four questions about this fast-moving field.

multidisciplinary sciences

China sets new ethics rules for human studies

Ethics: China already has clear stem-cell guidelines

How should China set ethical guardrails for medical research?

Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

Experiments that led to the first gene-edited babies: the ethical failings and the urgent need for better governance

Conflict of Interest in Scientific Research in China: A Socio-ethical Analysis of He Jiankui’s Human Genome-editing Experiment

Debating Ethical Issues in Genome Editing Technology

Patient privacy and autonomy: a comparative analysis of cases of ethical dilemmas in China and the United States

Breaking the germline barrier in a moral vacuum

Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China

China's New Regulations on Generative AI: Implications for Bioethics.

Translational Bioethics in China: Brain-Computer Interface Research as a Case Study

UK Scientists Reject Call for Moratorium on Gene Editing

Recent Developments in the Regulation of Heritable Human Genome Editing

Ethics Committees Promote Responsible Research in China

Before and after the Chinese gene-edited human babies: Multiple discourses of gene editing on social media

Comments on the CRISPR Gene-edited Babies’ Case

An ethical pathway for gene editing.

China's regulatory change toward genome-edited crops

Germline genome editing of human IVF embryos should not be subject to overly stringent restrictions

The CRISPR-baby scandal: what’s next for human gene-editing